Ethris
Manufacturing · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Semmelweisstr. 3, Planegg, Bavaria, 8215...Phone Number
+49 8989557880Website
www.ethris.comRevenue
$23.6 MillionIndustry
About Ethris
Is Ethris your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Ethris recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Ethris is spiking on competitors!
Click to see if Ethris had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Ethris
Product Launch: Get notified when Ethris launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Ethris has new funding data
Ethris, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Ethris has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Ethris
Find 3 more new buyers
Company Profile Activity
Activity Insights
Ethris is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ethris is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ethris.
Ethris financials insights
Gather financial insights about Ethris, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$28M
Series B
$26.3M
Other Financing Round
$5M
Ethris Tech Stack
A closer look at the technologies used by Ethris
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ethris
Ethris has paved a new path from genes to therapeutic proteins using its proprietary, non-immunogenic messenger RNA technology platform to discover, design and develop innovative therapies. With more than a decade as an mRNA pioneer, the company is a global leader in delivering stabilized mRNAs directly to the respiratory system via optimized formu... Read More